Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
26.50
-0.82 (-3.00%)
Nov 20, 2026, 4:00 PM EST - Market closed
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of $1.36 billion as of November 20, 2026. Its market cap has increased by 31.81% in one year.
Market Cap
1.36B
Enterprise Value
1.35B
1-Year Change
31.81%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since the IPO on December 11, 2020, Nanobiotix's market cap has increased from $549.07M to $1.36B, an increase of 147.30%. That is a compound annual growth rate of 16.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.36B | 22.59% |
| Dec 31, 2025 | 1.11B | 646.33% |
| Dec 31, 2024 | 148.41M | -57.08% |
| Dec 29, 2023 | 345.77M | 156.45% |
| Dec 30, 2022 | 134.83M | -53.41% |
| Dec 31, 2021 | 289.40M | -50.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 (IPO) | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Windward Bio Group AG | 1.41B |
| Nurix Therapeutics | 1.40B |
| Intellia Therapeutics | 1.40B |
| Tyra Biosciences | 1.39B |
| AnaptysBio | 1.39B |
| Rapport Therapeutics | 1.37B |
| Immunocore Holdings | 1.36B |
| uniQure | 1.36B |